Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of PROs in Late Onset Hypogonadism
NCT00254553Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of testosterone in Hypogonadism, sponsored by Merck & Co.. Started Jul 2005; status: terminated.
02
Drugs
testosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00254553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254553.